Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (15415)	2/19/1998 11:05:00 PM
From: Brian Moore	Read Replies (5) \| Respond to of 32384

Barry, don't worry about name calling. It's no big deal to me. I actually kind of like Ligand, though I don't know enough to buy yet. After seeing it praised for a year and a half by so many people in this thread, many times intimating that a run up is just around the corner, and then noticing that the price is about the same as when the thread started, I just kinda wonder. The true believers really have not done too well. That TonyT seems to bother some people, but to me he has a legitimate role, sort of the court jester. All the fancy people on this thread, with all the fancy messages, but the stock doesn't go up. Then he drops by and tells us what happened with Dell. Those people will go away if the stock makes a few moves. Until then, he should be able to make his point about the benefits of past investments in Dell instead of Ligand because he is, after all, right.

To: Machaon who wrote (15415)	2/19/1998 11:12:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Bob, Actually, my "spin" was a quick read as I was heading out the door and Yahoo had the press release up before I received a FAX, so I didn't have a release to refer to as I posted. My post was just meant to give a quick take on the release, which I viewed at the time (and still view) as a strong signal for investors that LGND was moving into a marketing and sales phase. Of course business development is a broader title and LGND is moving forward in that area also. I expect an announcement on the licensing of the GLYC technology to come out very soon. I also expect a leptin deal soon, although I suspect (but have not verified) that it will be with a new partner. I expect LGND to move forward on many fronts, which will keep Mirto to be very busy. The press releases are rather obvious. I'm a bit surprised that so much explanation is necessary, but peer influence is rather strong and some people may actually believe some of the gibberish that is posted on this board on an all too frequent basis.